"The radiologist who reviewed my CT scan provided insights that my local doctor hadn't mentioned. This helped me make a more informed decision about my treatment options."
PJ
Priya Joshi
Expert Medical Second Opinions
Get a Second Opinion for Lung Cancer Genomic Panel
Get an expert second opinion on your Lung Cancer Genomic Panel results from India's leading thoracic oncologists and molecular pathologists. Our specialists review EGFR, ALK, ROS1, KRAS G12C, MET, BRAF, RET, NTRK, TMB, and PD-L1 findings to confirm targeted therapy eligibility, immunotherapy suitability, and clinical trial options for your specific lung cancer subtype.
4.9/5 Patient Rating
Verified Specialists
Private & Confidential
Expert Medical Second Opinions
Get a Second Opinion for Lung Cancer Genomic Panel
Get an expert second opinion on your Lung Cancer Genomic Panel results from India's leading thoracic oncologists and molecular pathologists. Our specialists review EGFR, ALK, ROS1, KRAS G12C, MET, BRAF, RET, NTRK, TMB, and PD-L1 findings to confirm targeted therapy eligibility, immunotherapy suitability, and clinical trial options for your specific lung cancer subtype.
4.9/5 Patient Rating
Verified Specialists
Private & Confidential
How our second opinion works
Clear steps. Expert review. Better decisions.
Our process is designed to feel simple, fast, and reassuring — from sharing your case to receiving a specialist-backed second opinion and the support to act on it.
Step 1
Step 1
Share your case
Tell us your symptoms, diagnosis, and what you want reviewed.
A care coordinator helps capture the right information so your review starts with clarity.
Fast intakeCare coordinator
Step 2
Step 2
Upload reports
Add scans, biopsy reports, prescriptions, and past treatment notes.
We organize your records securely so the specialist can review everything in one place.
Secure uploadRecord review
Step 3
Step 3
Expert review
A top specialist studies your case and prepares a clear second opinion.
You get practical guidance on diagnosis confirmation, treatment alternatives, and next steps.
24–48 hrsWritten report
Step 4
Step 4
Plan your next step
Discuss the report and get help choosing the right doctor or hospital.
Our team supports follow-up questions, appointment booking, and care navigation.
Follow-up helpBooking support
Your second opinion may help confirm a diagnosis, avoid unnecessary procedures, identify better treatment options, and give you more confidence before making a major health decision.
Why Choose BigOHealth Second Opinion for Lung Cancer Genomic Panel?
Get Clarity
Understand your diagnosis with expert interpretation of medical reports and test results.
- Clear explanation of complex medical terms
- In-depth report and scan analysis
- All your questions answered by experts
Confirm Diagnosis
Get an independent review of your diagnosis by board-certified oncologists.
- Expert second opinion by top oncologists
- Pathology and biopsy report verification
- Accurate cancer staging confirmation
Explore Options
Learn about alternative treatments and new possibilities tailored to your condition.
- Review of alternative treatment approaches
- Access to relevant clinical trials
- Insights into the latest medical advancements
Here's why patients trust us:
Expert Review
Expert Review of your diagnosis and reports by top Lung Cancer Genomic Panel specialists
Personalized Treatment Options
Personalized Treatment Options tailored to your specific Lung Cancer Genomic Panel type and stage
Fast Turnaround Time
Get Callback within 2 Hours
Confidential & Secure
Your data stays private and protected
Pan-India Access
Consult top Lung Cancer Genomic Panel specialists, no matter where you are
No spam. Call back within 2 hours.
How a second opinion helps with lung cancer genomic panel
Genomic and NGS reports are complex. An expert molecular review confirms which findings are truly actionable and guides the right therapy decision.
How a second opinion helps you
- Confirm variant classification: pathogenic, likely pathogenic, or VUS
- Identify all actionable mutations that match targeted therapies or trials
- Verify TMB, MSI, and PD-L1 findings before immunotherapy decisions
- Get a clear, mutation-matched treatment or prevention plan
Questions to ask your doctor
Questions to ask doctor for second opinion for lung cancer genomic panel
Bring these questions to your consultation to get clear, confident answers.
Is the variant identified in my Lung Cancer Genomic Panel correctly classified as pathogenic, likely pathogenic, or VUS?
Which findings in my Lung Cancer Genomic Panel report are truly actionable for treatment decisions?
Does my Lung Cancer Genomic Panel result make me eligible for targeted therapy, immunotherapy, or PARP inhibitors?
Are there any additional genomic or biomarker tests I should do alongside Lung Cancer Genomic Panel?
What clinical trials match my specific Lung Cancer Genomic Panel findings?
How should my Lung Cancer Genomic Panel result affect decisions for family members who may be at risk?
Which variants of uncertain significance in my Lung Cancer Genomic Panel report might be reclassified in the future?
How often should I repeat Lung Cancer Genomic Panel testing to track resistance or disease evolution?
Document checklist
Document checklist for Lung Cancer Genomic Panel second opinion
Full lung cancer NGS / genomic panel report with all mutations, fusions, TMB, and MSI status
Pathology / histopathology report confirming lung cancer type (adenocarcinoma, squamous, SCLC, etc.)
CT chest, PET-CT, or MRI reports and images showing disease extent and staging
PD-L1 immunohistochemistry report if available
Current or proposed targeted therapy or immunotherapy plan
Prior treatment history including TKI therapy and response / progression details
Other second opinions for your cancer case
What else should you get reviewed before starting treatment?
Most patients also confirm surgery need, PET-CT staging, or get a tumor board review before finalizing their treatment plan.
Multi-specialist cancer review
Tumor Board Review
Get a multidisciplinary cancer tumor board review for staging, treatment sequence, and complex decisions.
Get expert reviewBefore cancer surgery
Cancer Surgery Second Opinion
Confirm surgery need, operability, margins, reconstruction, and whether treatment should start before surgery.
Get expert reviewCT scan report review
CT Scan Second Opinion
Get an expert CT scan report review for tumor location, lymph nodes, spread, and treatment planning.
Get expert reviewPET-CT cancer staging
PET-CT Scan Second Opinion
Review PET-CT findings for cancer staging, recurrence, metastasis, and treatment response.
Get expert reviewExpert Medical Assessment
Why Get a Second Opinion for a Lung Cancer Genomic Panel?
When facing important health decisions about lung cancer genomic panel, getting a second opinion can provide clarity, confirm your diagnosis, and ensure you explore all treatment options.
Lung cancer targeted therapy depends entirely on accurate mutation identification — errors in EGFR exon, ALK fusion type, or KRAS variant can lead to wrong drug choices.
Different labs detect alterations with different sensitivity — a second review may identify actionable mutations missed initially.
PD-L1 scoring and TMB interpretation vary between labs and directly affect immunotherapy decisions.
Resistance mutations (EGFR T790M, C797S) after first-line therapy require expert review to select next-line therapy.
Confirm whether liquid biopsy (ctDNA) findings match tissue biopsy results for treatment planning.
Access to newer targeted agents and clinical trials depends on precise genomic classification.
Did you know?Studies show second opinions lead to changes in diagnosis or treatment plans in approximately 10-30% of cases across various medical specialties.
37%Average rate of diagnosis change after second opinion
98%Patients report increased confidence after second opinion
"Getting a second opinion for my lung cancer genomic panel condition completely changed my treatment path. The specialist identified options my local doctor hadn't mentioned."— BigOHealth Patient
Ready to get expert insight on your lung cancer genomic panel diagnosis or treatment plan?Request Your Second Opinion
No spam. Call back within 2 hours.
Patient Guidance
Who Should Get a Second Opinion for Lung Cancer Genomic Panel?
Consider seeking expert consultation if any of these scenarios apply to your lung cancer genomic panel condition.
Scenario 1
If your lung cancer NGS panel identified a mutation and you want to confirm the targeted therapy recommendation.
Scenario 2
If your panel returned no actionable mutation but symptoms and histology suggest targeted therapy may still be relevant.
Scenario 3
If you have progressed on first-line targeted therapy (e.g., EGFR TKI) and want expert review of resistance mechanisms.
Scenario 4
If PD-L1 score or TMB result is borderline and immunotherapy eligibility is unclear.
Scenario 5
If liquid biopsy and tissue biopsy results differ and you need help deciding which to act on.
Scenario 6
If you want to identify clinical trials matched to your specific lung cancer genomic profile.
Not sure if you need a second opinion?
Our medical team can help you determine if a second opinion would be beneficial for your specific situation. Contact us for a free consultation about your lung cancer genomic panel condition.
Why Patients Choose Second Opinions
- Confirm accuracy of initial diagnosis and staging
- Access to latest treatment protocols and clinical trials
- Expert review of pathology and imaging results
- Personalized treatment recommendations
- Peace of mind and confidence in your care plan
Consider a second opinion sooner if:
- Your Lung Cancer Genomic Panel report contains a variant of uncertain significance (VUS) affecting treatment decisions.
- A targeted therapy, PARP inhibitor, or immunotherapy is being recommended based on Lung Cancer Genomic Panel alone.
- Two labs or oncologists have given conflicting interpretations of your Lung Cancer Genomic Panel result.
- Risk-reducing surgery or preventive intervention is being considered based on Lung Cancer Genomic Panel findings.
This is guidance for planning, not emergency advice. For urgent symptoms, seek immediate care.
0%
of patients feel more confident after a second opinion
0 in 0
second opinions change the treatment plan
What You'll Get
Our comprehensive second opinion service provides expert review, consultation, and a clear treatment path.
Report Review
Thorough evaluation of medical records and scans by oncologists.
- Pathology report analysis
- Imaging & test result review
- Treatment history evaluation
Doctor Consultation
Personalized 1-on-1 consultation with a senior doctor.
- 30-minute consultation
- Interactive Q&A session
- Treatment options discussion
Personalized Plan
Written report with expert recommendations and next steps.
- Treatment summary
- Care recommendations
- Relevant resources
Report Review
Thorough evaluation of medical records and scans by oncologists.
- Pathology report analysis
- Imaging & test result review
- Treatment history evaluation
Doctor Consultation
Personalized 1-on-1 consultation with a senior doctor.
- 30-minute consultation
- Interactive Q&A session
- Treatment options discussion
Personalized Plan
Written report with expert recommendations and next steps.
- Treatment summary
- Care recommendations
- Relevant resources
Common Questions
Frequently Asked Questions About Lung Cancer Genomic Panel Second Opinions
Get expert answers about our second opinion process for lung cancer genomic panel, specialist consultations, and how our medical experts can help confirm your diagnosis and treatment plan.
Q: What mutations are tested in a lung cancer genomic panel?
A: A lung cancer genomic panel typically covers EGFR (including exon 19, 21, T790M, and other variants), ALK fusions, ROS1 fusions, KRAS G12C, MET exon 14 skipping and amplification, BRAF V600E, RET fusions, NTRK fusions, HER2, and immunotherapy markers TMB and PD-L1. Each mutation has specific approved or investigational targeted therapies, which makes accurate interpretation critical.
Q: What documents are needed for a lung cancer genomic panel second opinion?
A: Provide the full NGS / genomic panel report with all mutations, fusions, TMB, and MSI status; pathology report confirming lung cancer type (adenocarcinoma, squamous cell, SCLC, etc.); CT, PET-CT, or MRI reports with staging details; PD-L1 IHC report if available; current or proposed targeted therapy or immunotherapy plan; and prior treatment history including TKI therapy and progression details.
Q: Can a second opinion change my targeted therapy choice for lung cancer?
A: Yes — particularly in EGFR-mutant lung cancer where the specific exon and mutation type (exon 19 deletion vs L858R vs uncommon variants) determines which TKI is most effective. In ALK-positive disease, fusion partner type influences drug selection and resistance patterns. Our thoracic oncologists ensure the right drug is matched to the right mutation.
Q: My lung cancer NGS shows no actionable mutation. What are my options?
A: A 'no actionable mutation' result redirects treatment toward chemotherapy or immunotherapy based on PD-L1 expression and TMB. However, different labs have different gene coverage — a second opinion can confirm whether a broader panel or liquid biopsy should be done, and whether immunotherapy eligibility has been correctly assessed based on your PD-L1 score and TMB level.
Q: What does EGFR T790M mean after first-line treatment?
A: EGFR T790M is the most common resistance mutation that develops after first-generation EGFR TKI therapy (erlotinib, gefitinib, afatinib). Its presence indicates eligibility for third-generation TKI therapy (osimertinib). T790M testing should be done via liquid biopsy or repeat tissue biopsy at progression. Our specialists confirm the correct resistance mutation and next-line therapy.
Q: How do liquid biopsy and tissue biopsy results compare for lung cancer genomic testing?
A: Liquid biopsy (ctDNA from blood) is non-invasive and useful for detecting resistance mutations at progression, but it may miss low-level mutations or have false negatives when tumor shedding is low. Tissue biopsy provides more complete genomic information but requires a procedure. When results differ, tissue biopsy is generally considered more authoritative. Our team reviews both results together to guide the most informed treatment decision.
Get Your Lung Cancer Genomic Panel Second Opinion
No spam. Call back within 2 hours.
Patient Voices & Experiences
Real experiences from Indian patients & caregivers navigating multidisciplinary cancer care.
"I was hesitant about the extensive dental work recommended by my local dentist. The dental specialist at BigOHealth suggested a more conservative approach that saved me money and discomfort."
VT
Vikram Thakur
"After my cancer diagnosis, I was uncertain about the treatment plan. BigOHealth connected me with an oncology specialist who provided a detailed second opinion that gave me confidence in my treatment decisions."
RP
Rajesh Patel
"The neurologist who reviewed my case found a subtle issue missed in my initial diagnosis. This changed my treatment approach completely and improved my quality of life significantly."
SM
Sunita Mehta
"I was recommended surgery for my knee pain, but wasn't convinced it was necessary. The orthopedic specialist at BigOHealth suggested physical therapy first, which completely resolved my issue without surgery."
AK
Arun Kumar
"When I was diagnosed with lung cancer, I was overwhelmed. The pulmonary oncologist at BigOHealth reviewed my scans and pathology, revealed I was eligible for targeted therapy, and helped me understand my options clearly. This second opinion changed my treatment trajectory."
DS
Deepak Singh
"After being told I needed extensive jaw surgery for oral cancer, I was terrified of losing my ability to eat and speak normally. BigOHealth connected me with an oral oncologist who showed me reconstruction options that preserved function. I'm grateful for that second opinion."
MK
Meera Kapoor
"Hi! Yes it went well and we got answers to all our questions. He explained in detail all the scenarios and also what to expect post surgery. Thank you for scheduling the call, it was very helpful!"
P
Patient
"The radiologist who reviewed my CT scan provided insights that my local doctor hadn't mentioned. This helped me make a more informed decision about my treatment options."
PJ
Priya Joshi
"I was hesitant about the extensive dental work recommended by my local dentist. The dental specialist at BigOHealth suggested a more conservative approach that saved me money and discomfort."
VT
Vikram Thakur
"After my cancer diagnosis, I was uncertain about the treatment plan. BigOHealth connected me with an oncology specialist who provided a detailed second opinion that gave me confidence in my treatment decisions."
RP
Rajesh Patel
"The neurologist who reviewed my case found a subtle issue missed in my initial diagnosis. This changed my treatment approach completely and improved my quality of life significantly."
SM
Sunita Mehta
"I was recommended surgery for my knee pain, but wasn't convinced it was necessary. The orthopedic specialist at BigOHealth suggested physical therapy first, which completely resolved my issue without surgery."
AK
Arun Kumar
"When I was diagnosed with lung cancer, I was overwhelmed. The pulmonary oncologist at BigOHealth reviewed my scans and pathology, revealed I was eligible for targeted therapy, and helped me understand my options clearly. This second opinion changed my treatment trajectory."
DS
Deepak Singh
"After being told I needed extensive jaw surgery for oral cancer, I was terrified of losing my ability to eat and speak normally. BigOHealth connected me with an oral oncologist who showed me reconstruction options that preserved function. I'm grateful for that second opinion."
MK
Meera Kapoor
"Hi! Yes it went well and we got answers to all our questions. He explained in detail all the scenarios and also what to expect post surgery. Thank you for scheduling the call, it was very helpful!"
P
Patient
Testimonials are personal experiences; individual outcomes & costs vary by clinical context.
Get Sahi Doctor, Sahi ilaj with BigOHealth App. Download it Now
